General Information of Drug Formulation (ID: F19292)

Formulation Name
Rivastigmine 1.5 mg capsule
Company
American Health Packaging; Carilion Materials Management; Sun Pharmaceutical Industries
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Rivastigmine DMG629M Alzheimer disease 8A20 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Ammonia E00007 222 Alkalizing agent
Butyl alcohol E00011 263 Flavoring agent; Solvent
D&C red no. 28 E00491 6097185 Colorant
Ferrosoferric oxide E00231 14789 Colorant
Magnesium stearate E00208 11177 lubricant
Potassium hydroxide E00233 14797 Alkalizing agent
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Quinoline yellow WS E00309 24671 Colorant
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sunset yellow FCF E00255 17730 Colorant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent